[ADVERT]
Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innovations Group Plc LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -3.51% 2.75 2.60 2.90 2.85 2.75 2.85 1,186,904 09:29:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 6.3 -3.3 -0.4 - 26

Surgical Innovations Share Discussion Threads

Showing 11601 to 11624 of 11700 messages
Chat Pages: 468  467  466  465  464  463  462  461  460  459  458  457  Older
DateSubjectAuthorDiscuss
23/3/2021
00:13
buywell says this is a commendable effort by the guys at SUN and EH Well Done hTtps://www.surginno.com/iwd-2019-2/ Resposable™ products reduce plastic waste in Operating Theatres by 83%* The equivalent of 52 plastic bottles, per surgery could be eliminated from incineration. Surgical Innovations have been leading the way in the reduction of plastic disposal since 1992. Increasingly large volumes of clinical waste are being incinerated by hospitals each year, a large percentage of this waste is from plastic materials. Hospitals are constantly under pressure to achieve cost savings and make improvements. The innovative design of Surgical Innovations Resposable™ product ranges provide a high quality reusable instrument with the clinical benefits of a small disposable element. Providing the solution for Hospitals looking to reduce costs and waste whilst maintaining reliability and quality. Disposing of a small item dramatically reduces the volume of waste and cost of disposal for the Hospital. The recurring cost of the small disposable element is also much less than a fully disposable device, providing two cost saving benefits. *We have produced a white paper which considers the role of fully disposable plastic instruments and the considerable issue of plastic waste in the Operating Theatre and examines the benefits of Resposable™ medical devices as an alternative. We also examine the consequential CO2 emissions of Operating Theatre waste management to provide a comparison aiding key decision-makers in the NHS and private healthcare. A few points of interest: « The NHS in England is responsible for around 20 million tonnes of Carbon Dioxide emissions annually and spends more than £50 million on Carbon Permits every year. (1) « Although Operating Theatres physically occupy a relatively small area in hospitals, they generate a disproportionate amount of waste. In the US, it is estimated that 20%-33% of all hospital waste is generated by the operating theatres and a single operation can generate more waste than a family of four produces in one week. (2,3) « Carbon Dioxide emissions attributable to the NHS are greater than all of the aircraft departing from London’s Heathrow Airport. (1) Conclusion: Management of waste in the Operating Theatre is a multifactorial task which should be managed around the 4 R’s (Reduce, Reuse, Recycle – Resposable™). Many of the solutions are simple – the provision of recycling bins in the OR suite so that cardboard packaging and paper IFU’s can be recycled easily. Others are much more difficult – reducing the amount of plastic waste in many operations requires a root-and-branch rethink by product manufacturers to dramatically reduce the amount of packaging and the volume of plastic used in instrumentation. In our example of the Laparoscopic Cholecystectomy, a typical fully disposable kit used in many hospitals all over the world weighs 713g. A kit comprising Resposable™ instruments weighs 82g. A difference of 631g. There are over 70,000 Cholecystectomies performed in the UK every year. If every case was converted to using Resposable™ instruments, this would represent a reduction of over 44,000kg of plastic waste per year. If a surgical instrument is equally effective, costs less than what is currently used and has the crucial benefit of dramatically reducing the CO2 footprint, then we are urging our NHS Hospitals to prioritise the consideration of this change. *Contact our UK subsidiary, Elemental Healthcare Ltd to read the full white paper and find out how to begin to reduce plastic waste in operating theatres by 83%. E: info@elementalhealthcare.co.uk T: 0844 412 0020 1. Health and climate change: policy responses to protect public health. Nick Watts, MA. Prof W Neil Adger, PhD. Paolo Agnolucci, PhD. Jason Blackstock, PhD. Prof Peter Byaa, PhD. Wenjia Cai, PhD. et al. 2015. 2015, The Lancet. 2. A quantitative, qualitative, and critical assessment of surgical waste. Surgeons venture through the trash can. Tieszen ME, Gruenberg JC. 1992. s.l. : JAMA, 1992, Vols. 1992;267:2765-8. 3. Wastage of supplies and drugs in the operating. Esaki RK, Macario A. 2009. s.l. : Medscape Anesthesiology 2009, 2009.
buywell2
22/3/2021
23:27
Add up this % list of major shareholders --- many of whom bought in at 3p to 4p hTtps://www.sigroupplc.com/major-shareholders-4 It's a big number isn't it ---- not a lot left for sale for them as wants em when good news breaks, and the Institutions are loyal and soon buywell believes that others will want in as MIS increases and robotic MIS becomes ever more necessary in a Covid-19 world And the Directors of EH who also got shares valued at 3p when Elemental Healthcare was acquired by Surgical Innovations Since then several good distribution deals have been announced/new 3rd party products added to the EH ever growing website to sell into the UK plus new SUN products coming to market with relevant IP and more to come. The new CEO and COO plus their new appointees have now imo found their feet ps Expect Dexter Robot NHS news soon plus more robotic news
buywell3
22/3/2021
14:22
The trades showing as sells at 2.7999 are buys. Well mine is .
kenone
22/3/2021
12:26
I think under 4p must be a buy. As for under3p - well I just topped up my holding at a smidge under 2.8 p. Still well undervalued this now.
kenone
22/3/2021
09:14
Yes buywell has already said that weeks ago on here With the chart and reasons as to why See BUY thread
buywell3
22/3/2021
09:13
more good news for the company with this agreement - tipped in cityconfidential in January and they reckon the shares could go back to 4p!
sharetips
22/3/2021
07:45
RNS Another Great Distribution deal and 3p beckons Microline owned by Japanese Mega Group HOYA worth gazillions $$$$ buywell adds Microline to possible acquirers of SUN as they add to their IP Surgical Innovations Group plc (AIM: SUN), the designer, manufacturer and distributor of innovative medical technology for minimally invasive surgery ("MIS"), announces that its wholly owned subsidiary, Elemental Healthcare Ltd ("Elemental") has signed an additional three-year exclusive GB distribution agreement with Microline Surgical Inc. ("Microline") for the distribution in Great Britain of Microline instruments. Based near Boston, MA, U.S.A. Microline designs, manufactures and distributes high quality instruments aimed at the MIS market. Its portfolio of products is complementary to those offered by SI with a focus on the Resposable (TM) ethos of cost and sustainability. Elemental has a long established relationship with Microline, and recently announced a new 5-year USA distribution agreement with Microline for the Company's range of YelloPort+Plus(TM) and YelloPort Elite(TM) Access Devices.. Adam Power, Surgical Innovations Group Development Director, says: "We are very pleased to announce an exclusive agreement for a further three years to sell products manufactured by Microline Surgical. Microline is Elemental Healthcare's longest standing distribution partner as well as our largest, and shares the philosophy of sustainability in its products which will play such an important part in hospital decision-making in the years to come." Isabelle Huysmans, General Manager Microline BV commented: "We are extremely happy to confirm the extension of the exclusive agreement for the next three years with our trusted partner, Elemental Healthcare, who embrace and embody our vision and values completely. Together we will continue to work passionately on sustainability to provide solutions to improve the quality of life for everyone. "
buywell3
22/3/2021
07:40
Extended relationship with microlne in the UK
jmf69
18/3/2021
09:20
The list of Institutional Investors in SUN reads better than some FTSE100 stocks The percentage of SUN that is owned by these larger Investors is now very large So getting shares for the PI in any quantity is not too good and as better news of Distribution deals comes that gets harder still eg expect news re Dexter and other Robotics soon The market in the USA for Fix8 in 2023 will imo earn SUN about $1M Which means according to my maths === see previous posts re Trocar sales and SUN surgical instrument sales with USA Distributors Microline and Alder ( both 5yr deals) Means SUN should in buywells opine be turning over circa $6M plus from the USA alone in 2023 That is without new products which will be coming to market over the next 12 months -- Trocars and others This stock has only just started to play catch up imo That AMS has not moved to acquire it at these levels has surprised buywell , when Fix8 has FDA approval in 2022 --- then the Mkt Cap of SUN should have risen a fair bit higher than it is today dyor
buywell3
18/3/2021
08:33
2.88 paid for 347k
jmf69
17/3/2021
21:23
yes it is called the buywell effect lol SUN along with its Elemental Healthcare acquisition which by the way have a very good new website with a lot of new products added Plus re buywell's posts on here and on the BUY thread about Covid-19/Obesity/Bariatric Surgery hTtps://www.elementalhealthcare.co.uk/latest-news/minimizer-banded-bariatric When aerosol spread is recognized by the CDC and WHO and EMA etc as the biggest cause of Covid-19 transmission --- then the focus on the super spreaders ie obese people 20% of whom in a recent study were responsible for over 80% of the aerosol output of the entire group --- actions to reduce obesity by bariatric keyhole surgery ie proactive and quick --- will be needed as Covid-19 keeps mutatin and producing more transmissible and lethal variants Check out these products hTtps://www.elementalhealthcare.co.uk/our-products SUN imo is cheap at this share price as it is and has been a profitable company in a good niche market where barriers to entry are now very high. Plus as recent RNS's have shown , SUN is recognized as a quality maker and supplier of MIS (keyhole) surgical instruments and materials and devices needed to carry out such surgery --- their NHS sales imo are helping hugely now in gaining sales traction in the USA and ROW 4p chartwise in imo very doable --- buywell notes the Advanced Medical Solutions (AMS) LiquiBand Fix8 initiative in America is coming along, today AMS said: 'The clinical trial for the LiquiBand Fix8 (R) US Pre-Market Approval process is progressing well and both trial results and surgeon feedback has been positive. It is expected that patient procedures will be complete in 2021 followed by FDA filing in 2022. US approval would be a significant milestone for the Group, being the first product of its type to enter the $250 million US hernia fixation market. ' 'This positive progress supports efforts to secure more specialist partners for LiquiBand Fix8 (R) which is expected to drive much stronger growth for this category globally as elective surgery volumes recover. ' hTtp://uk.liquiband.com/region/uk/liquiband-product-range-wound-closure/liquiband-fix8/ buywell has long held the opinion that AMS could be a buyer of SUN as it has recently renewed the rights to sell LiquBand Fix8 instrument which is made by SUN and remember SUN 100% own the IP of the device ---- but there are now several others
buywell3
17/3/2021
20:41
I wonder if there is something going on?
xylemflow
17/3/2021
20:26
Late 500k buy showing
jmf69
17/3/2021
17:04
Another tick up today. Noy long before results
jmf69
16/3/2021
19:53
Chart small cup formations at 2.25p/2.5p were formed If more positive news comes out say perhaps with the results then the chart might put in a bowl formation at 4p MA's now looking good and a RSI move back to 85 could do the job imo
buywell3
16/3/2021
16:06
Slowly but surely... not much stock around. Online only allowing me to buy 50k max
jmf69
08/3/2021
16:51
Results and investor presentation on 25th March
jmf69
04/3/2021
23:14
That chart above would imo suggest chartwise 4p as the next resistance level to be tested if the uptrend now started continues A vaccine led return to normal NHS operations commencements would help as the backlog needs to be addressed for many awaiting Keyhole surgery must have doubled or more in the last 9 months to 10 months The recent two USA Distribution deals will imo also keep the share price heading North News of a Dexter Deal with the NHS soon should imo get 3p tested More if it involves circa 4 or 5 NHS Hospital Trusts which imo would indicate a more general NHS consensus towards a likely growing adoption of the technology and the preference of a lease model rather than the more costly outright purchase of such robotic machines which can cost around $1M apiece buywell would like to draw readers attention to something which has been said by SUN recently , namely : " Collaborations on early stage projects with a number of robotic manufacturers who have recognised the Company's expertise in access devices and instruments; these represent exciting opportunities over the longer term " Notice the plural usages -- ' a number of robotic manufacturers ' This imo means NEW robotic manufacturers other than Distalmotion the maker of Dexter Since SUN are the UK Distributor for Dexter/Distalmotion ie sell into the NHS IMO this could mean other robotics sales possibilities involving other robotics manufacturers in other countries , possibly the design and production of NEW bespoke innovative Keyhole surgical instruments designed specifically or tailor made to suit the individual robot hand and for a specific type of surgery or application within the Minimal Invasive Surgery area the robot is to be used . The use of robots for keyhole surgery in an endemic or pandemic Health Service setting looks set to accelerate given virus aerosol spread within operating theatres and ICU's and various Hospital rooms coupled with staffing burnout/shortages/mental stress and sickness issues. Robots can help doctors and nurses minimise virus inhalation as best as possible remembering that a number of patients undergoing surgery from now on will be asymptomatic patients and will not have tested positive for Covid-19 or any other virus or variant of a virus they might have in the future. A large hospital-wide screening programme has shown that 30 of 61 (49%) SARS-CoV-2 positive Hospital Care Workers HCWs were asymptomatic. The use of robots for both surgery procedures and disinfection control is a must imo to tackle Hospital acquired Covid-19 as it is a major problem: Minimising direct contact between patients and Hospital staff who then might get infected themselves and pass on the virus to other patients of days that follow is an obvious area needing attention. Robots do this as they can be controlled from many metres away in an adjoining room or clean air controlled cubicle. 18th December 2020 A Health Service Journal analysis of NHS England data found that around one in four covid cases was probably caught by hospital inpatients initially admitted for other reasons. The rates were over one in three in some hospitals and had risen by 35% in one week. NOT GOOD htTps://www.bmj.com/content/372/bmj.n70 This can not be allowed to continue during virus surges in the future : At some trusts, the weekly total of likely hospital-acquired covid-19 infections has more than doubled since last week htTps://www.hsj.co.uk/patient-safety/covid-infections-caught-in-hospital-rise-by-a-third-in-one-week/7029211.article ----------------------------------------------------------------------------- ---- The size and nature of the problem of Hospital acquired Covid-19 --- ----------------------------------------------------------------------------- Nosocomial transmission is also known as Hospital transmission Nosocomial meaning ---- originating in a hospital. 6th January 2021 Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers hTtps://aricjournal.biomedcentral.com/articles/10.1186/s13756-020-00875-7 Nosocomial outbreaks of SARS-COV-2 can be as high as 60% This is not good enough and the use of robots can help get that percentage down dyor
buywell2
23/2/2021
02:59
I think what buywell2 refers to regarding trocars is something the company recently said, namely : Ongoing progress in developing a partnership with a key MIS player to distribute our range of Elite and YP+ access devices in the US, with a training and evaluation phase anticipated to successfully conclude in Q1 2021. The global trocar market is estimated to be worth $561m in sales in 2020, with the US accounting for approximately $152m or 27% Since they said that buywell has read that the USA accounts for circa 50% of the Global trocar market , the key MIS USA player being Microline as we now know. Again regarding trocars , the company also recently stated : Surgical Innovations is developing a pipeline of both line extensions and new devices to market over the next 18 months, including larger diameter YP+ trocars to accommodate other devices that are more routinely used in this market and the associated introduction of an Optical 5mm trocar from H2 2021. So we can expect news soon of both new trocars most likely the 5mm optical trocar being the first in H2 of this year A decent circa 7% CAGR anticipated for trocars htTps://www.meticulousresearch.com/product/trocars-market-4948 But imo reusable trocars and optical reusable trocars ( reduced plastic waste = green) will be doing better than that Access with optical trocars has been demonstrated to be faster, associated with a lower incidence of wound infections, trocar hernias and smaller incisions but rare injuries to bowel, blood vessels, liver and omentum have also been reported. Our objective was to review our experience with the use of optical trocar entry and compare it with the open techniques. Bladeless Optical Trocars Market is Growing Massively htTps://www.openpr.com/news/1892161/bladeless-optical-trocars-market-is-growing-massively The bladeless trocars segment is estimated to witness the highest CAGR for the forecast period. The factors can be attributed to the advantages such as ease-of-use of bladeless tip trocars, no trauma to the internal body organs and vessels. The ergonomic design of these trocars offers high stability thus fueling the demand for this market segment. dyor
buywell3
19/2/2021
22:08
They did not put a number on the recent 5yr USA Trocar Deal with Microline unlike the one with USA Adler Surgical also 5yr and valued at $12M The market for Trocars is big in the USA , also specialist Microline in a BIG player in America and was not selling or making its own brand of Trocar That it chose SUN speaks volumes , the trocar market for SUN through Microline could be arguably bigger as SUN has yet newer trocars soon to come to market which presumably Microline will also sell into the USA Perhaps a number might then be put on the 5yr sales deal , $12M ? If so that would be $24M USA sales over 5 years = Nearly $5M a year added to turnover or around 3.5M GBP a year of which imo at least 1M would be profit Then there is the ROW to sell the new Trocar range into plus other new products coming to market
buywell2
17/2/2021
14:54
Everyone jumping into retail and travel shares.But the improving covid situation will benefit hospitals and surgeries first. Hospitals will empty out of Covid patients, so elective surgeries can ramp up.SUN is facing three amazing tailwinds. Huge boom in elective surgeries next two+ years, new products (Cellis, Dexter, etc) to sell this year vs last year. New expanded distribution in the USA.With so many things, growth vs 2019 is more than assured, yet the shares are being valued as though we'd only get back to 2019 levels.
boonkoh
17/2/2021
08:03
BBC News - Hospital waiting list 'may double to 10m by April'https://www.bbc.co.uk/news/health-56086978
jmf69
16/2/2021
21:32
=========== 4.5 Million now waiting to get hospital treatment ========== And that is in England and the number is rising Compounded problems exist with nurses and doctors facing stress/burnout and PTSD mental health issues which due to the shortfall of nurses ( approx 50,000) is also getting worse A British Medical Association Dec 2020 survey of 7,000 doctors recently found the following: 28% want to retire earlier than previously planned 21% are considering leaving the NHS for another career ------------------------------------------------------------ Nurses are arguably in an even worse state especially in ICU settings where previous NHS/Government staff planning allowed for one ICU patient per one ICU nurse As ICU bed demand has outstripped ICU beds by multiples Every ICU nurse has had to look after multiples of patients --- stress burnout and PSTD look now set to become the norm amongst the majority now the norm The CEO of Londons largest Health Trust has recently stated : Critical care staff working in the areas worst hit by the virus were reporting “high levels” of post-traumatic stress disorder (PTSD) and teams of phycologists have been brought in. hTtps://www.bbc.com/news/health-55766409 ------------------------------------------------------ What is the answer ? Not easy this, as Covid-19 is not going away and the chances of another covid wave looms large if present lockdowns are released too soon or variants create new cases You can't magic more nurses or doctors in the numbers needed But you can employ more Robot nurse helpers and use more robots to carry out surgeries You can also look after and protect the limited resource of NHS staff in the front line ( including cleaners ) and all those whose duties take them into high risk zones like ICU's and Operating rooms and wards that have covid-19 patients in them --------------------------------------------------------------- Another BMA survey of doctors and medical students , just carried out in GP practices and Hospitals has reported that over 66% did not feel safe at work due to Covid-19 concerns in that they did not feel 'fully protected' from the virus For the survey doctors were asked the question : Taking everything into account do you feel safely protected from coronavirus infection in your place of work 8% of doctors answered that they did not feel protected at all and another 64% answered that they felt partly protected One of their concerns being the need for better protective masks Another being safe covid secure rest facilities Both imo can be done imo by the use of UV-C and Far-UVC technologies ------------------------------------------------------------
buywell3
15/2/2021
13:45
positive comment in cityconfidential www.cityconfidential.co.uk
sharetips
Chat Pages: 468  467  466  465  464  463  462  461  460  459  458  457  Older
ADVFN Advertorial
Your Recent History
LSE
SUN
Surgical I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210917 17:22:25